Everyone knows one of the greatest benefits of decentralized trials is the ability to capture a greater diversity, better choice and streamlined experience for participants. All these things should lead to better study quality and improved retention.

But delivering on this promise involves jumping through a number of different hoops. How do we really offer flexible platforms that give sponsors, sites & patients choice? How do we really design things from a patient perspective without losing scientific rigor? How do we harness technology to improve data collection and enable the convenience of eSource & eConsent without alienating or confusing?

This is a leadership workshop designed to help you solve the design and interoperability challenges that should be imperative in modern trials, and how we can break the shackles that still hold us back. You’ll leave with the plan and confidence to finally make 2022 the year where pharma embraces DCT design developments.